secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2022-09-01T23:59:59+00:00
Accession:  0001493152-22-024846
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health reduces officer cash salaries, issues stock; director Jennings resigns
--------------------------------------------------------------------------------

- Christine Jennings resigned as director effective Aug 26, 2022; no disagreement stated.
- CEO Ajjarapu's base salary reduced from $360k to $300k cash plus $60k in stock for 12 months.
- President Patel and CFO Huffman took cash salary cuts of $10k and $25k respectively, replaced with stock.
- Employees accepted $37k aggregate cash reduction for 31,896 restricted shares.
- Independent director annual cash retainer cut to $26,750; each director gets 54,525 shares valued at $63,250.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222024846/0001493152-22-024846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222024846/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-024846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer